Javascript must be enabled to continue!
Epidemiological data on lower limb lymphedema
View through CrossRef
Objective: The aim of the present study was to evaluate epidemiological data of patients seen at a clinic specialized in the treatment of lymphedema. Methods: A retrospective, cross-sectional study was conducted involving data from 150 consecutive patients with lower limb lymphedema in clinical stages II and III treated at the Godoy Clinic in São Jose do Rio Preto. The follow data were collected: sex, age, type of lymphedema (primary or secondary), cause of secondary lymphedema (cancer, trauma, venous disease) and limb dominance. The diagnosis of lymphedema was based on the clinical history and physical examination; in cases of doubt, lymphoscintigraphy of the lower limbs was requested. Descriptive statistics were performed and results were expressed as percentages. Results: Twenty-five (16.66%) of the patients were male and 125 (83.33%) were female. Mean age was 42.52 years (41.8 years among the men and 42.67 years among the women). One hundred nine cases (72.66%) were primary lymphedema and 41 (27.33%) were secondary. Among the secondary cases, 27 (18%) were related to cancer treatment, 10 (6.6%) were linked to trauma and four (2.6%) were cases of phlebolymphedema. Mean age was 51.4 years among the patients with cancer treatment-related lymphedema, 41 years among those with trauma-related lymphedema and 64.25 years among those with phlebolymphedema. The left leg was affected in 61 cases (40.66%), the right leg was affected in 37 cases (24.66%) and lymphedema was bilateral in 52 cases (34.66%). Conclusion: Primary lymphedema was predominant and affected women more than men. Primary lymphedema occurred at an earlier age compared to cancer treatment-related lymphedema and phlebolymphedema. The left leg was affected more often, followed by bilateral lymphedema and, finally, the right leg alone.
Title: Epidemiological data on lower limb lymphedema
Description:
Objective: The aim of the present study was to evaluate epidemiological data of patients seen at a clinic specialized in the treatment of lymphedema.
Methods: A retrospective, cross-sectional study was conducted involving data from 150 consecutive patients with lower limb lymphedema in clinical stages II and III treated at the Godoy Clinic in São Jose do Rio Preto.
The follow data were collected: sex, age, type of lymphedema (primary or secondary), cause of secondary lymphedema (cancer, trauma, venous disease) and limb dominance.
The diagnosis of lymphedema was based on the clinical history and physical examination; in cases of doubt, lymphoscintigraphy of the lower limbs was requested.
Descriptive statistics were performed and results were expressed as percentages.
Results: Twenty-five (16.
66%) of the patients were male and 125 (83.
33%) were female.
Mean age was 42.
52 years (41.
8 years among the men and 42.
67 years among the women).
One hundred nine cases (72.
66%) were primary lymphedema and 41 (27.
33%) were secondary.
Among the secondary cases, 27 (18%) were related to cancer treatment, 10 (6.
6%) were linked to trauma and four (2.
6%) were cases of phlebolymphedema.
Mean age was 51.
4 years among the patients with cancer treatment-related lymphedema, 41 years among those with trauma-related lymphedema and 64.
25 years among those with phlebolymphedema.
The left leg was affected in 61 cases (40.
66%), the right leg was affected in 37 cases (24.
66%) and lymphedema was bilateral in 52 cases (34.
66%).
Conclusion: Primary lymphedema was predominant and affected women more than men.
Primary lymphedema occurred at an earlier age compared to cancer treatment-related lymphedema and phlebolymphedema.
The left leg was affected more often, followed by bilateral lymphedema and, finally, the right leg alone.
Related Results
Anti-CTLA4 treatment reduces lymphedema risk through a systemic expansion of the FOXP3+ Treg population
Anti-CTLA4 treatment reduces lymphedema risk through a systemic expansion of the FOXP3+ Treg population
Abstract
Secondary lymphedema is a common sequel of oncologic surgery following lymphatic injury and presents a substantial global health burden for which no pharmacologica...
Lympedema Therapies
Lympedema Therapies
Secondary lymphedema refers to a condition in which the affected extremity develops progressive hypertrophy due to lymphatic fluid retention. Worldwide, secondary lymphedema is mos...
Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review
Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review
Background:
Lymphovenous anastomosis (LVA) is an accepted microsurgical treatment for lymphedema of the upper extremity (UE). This study summarizes and analyzes recent ...
Mobiderm Autofit Garments for Reducing Lower Limb Lymphedema: A Single-Arm Study Exploring Underlying Mechanisms
Mobiderm Autofit Garments for Reducing Lower Limb Lymphedema: A Single-Arm Study Exploring Underlying Mechanisms
Background: Lymphedema is a chronic, disabling condition that results from a dysfunctional lymphatic system. The Mobiderm® Autofit device is designed to apply pressure and mobilize...
Management of Lower Limb Varicose Veins Using Endovenous Laser Ablation, Micro-Phlebectomy, and Sclerotherapy Using Multimodal Analgesia
Management of Lower Limb Varicose Veins Using Endovenous Laser Ablation, Micro-Phlebectomy, and Sclerotherapy Using Multimodal Analgesia
Abstract
Introduction
Previously, the conventional surgical procedure of high-ligation and saphenous stripping was commonly used to treat varicose veins (VVs). However, contemporar...
The lymphedema patient experience within the healthcare system: a cross-sectional epidemiologic assessment
The lymphedema patient experience within the healthcare system: a cross-sectional epidemiologic assessment
AbstractLymphedema is a progressive lymphatic disease that potentiates physical and psychosocial distress. Despite its impact, patients reportedly encounter lymphatic ignorance thr...
The Kinetics of Lymphatic Dysfunction and Leukocyte Expansion in the Draining Lymph Node during LTB4 Antagonism in a Mouse Model of Lymphedema
The Kinetics of Lymphatic Dysfunction and Leukocyte Expansion in the Draining Lymph Node during LTB4 Antagonism in a Mouse Model of Lymphedema
The mechanisms of lymphedema development are not well understood, but emerging evidence highlights the crucial role the immune system plays in driving its progression. It is well k...
Characterizing Trends of Lymphedema After Axillary Lymph Node Dissection with and Without Immediate Lymphatic Reconstruction
Characterizing Trends of Lymphedema After Axillary Lymph Node Dissection with and Without Immediate Lymphatic Reconstruction
Background and Objectives: Breast cancer-related lymphedema (BCRL) is a complication of axillary lymph node dissection (ALND). Immediate lymphatic reconstruction (ILR) may help to ...


